Climate change is expected to increase to extreme temperatures and lead to more intense formation of near-surface ozone. Higher temperatures can cause heat stress and ozone is a highly oxidative pollutant; both increase cardiorespiratory mortality. Using greenhouse gas and ozone precursor emission scenarios, global and regional climate and chemistry-transport models, epidemiological data, and population projections, we projected ozone-and heat-related health risks under a changing climate. European near-surface temperature was modelled with the regional climate model (RCA4), forced by the greenhouse gas emission scenario RCP4.5 and the global climate model EC-EARTH, and near-surface ozone was modelled with the Multi-scale Atmospheric Transport and Chemistry (MATCH) model. Two periods were compared: recent climate in 1991-2000 and future climate in 2046-2055, projecting around a 2°increase in global temperatures by that time. Projections of premature mortality considered future climate, future population, and future emissions separately and jointly to understand the relative importance of their contributions. Ozone currently causes 55 000 premature deaths annually in Europe due to long-term exposure, including a proportion of the estimated 26 000 deaths per year due to short-term exposures. When only taking into account the impact of a changing climate, up to an 11% increase in ozone-associated mortality is expected in some countries in Central and Southern Europe in 2050. However, projected decreases in ozone precursor emissions are expected to result in a decrease in ozone-related mortality (−30% as EU average). Due to aging and increasingly susceptible populations, the decrease in 2050 would be smaller, up to −24%. During summer months, ozone risks could combine with increasing temperatures, especially during the hottest periods and in densely populated urban areas. While the heat burden is currently of the same order of magnitude as ozone, due to increasing temperatures and decreasing ozone precursor emissions, heat-related mortality could be twice as large as ozone-related mortality in 2050.
Introduction
The relationship between climate change, higher temperatures, and near-surface ozone formation and mortality is well established. Climate change is expected to increase global temperatures (IPCC 2013) and the probability of heat extremes (Christidis et al 2014 , Seneviratne et al 2014 ; both have substantial effects on human health (Hajat and Kosatky 2010 , Astrom et al 2011 , Gasparrini et al 2015 . Tropospheric ozone is a secondary pollutant, formed by the reactions of a mixture of nitrogen oxides and methane, Original content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence.
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carbon monoxide and non-methane volatile organic compounds from biogenic and anthropogenic sources. Biogenic emissions of ozone precursors are dependent on temperature, solar radiation and available moisture in air and soils (Andersson and Engardt 2010) . The rate of formation of ozone in the troposphere is dependent on photolytically available sunlight (i.e. cloudiness, time of day, and latitude) and some of the involved reaction rates are temperaturedependent (Atkinson et al 2006) . Mixing height, wind speed, and direction are also important meteorological factors. Studies have shown a dependency in nearsurface ozone concentration on such meteorological factors, for example a positive correlation with temperature (Coates et al 2016) . Therefore, changes to cloudiness, moisture, wind patterns, boundary layer height, and temperatures in the future could lead to changes in ozone concentrations, however the relevant processes are complex and advanced models are needed to understand the change. The impact of climate change on near-surface ozone in Europe has been studied extensively with such models, showing that there will likely be a climate penalty in central and southern Europe, i.e. increased ozone with climate change (Jacob and Winner 2009 ). Nevertheless, due to political and subsequent technological efforts, anthropogenic ozone precursor emissions have decreased since the 1990s and are expected to continue decreasing in the future-both in north America and Europe (Hidy and Blanchard 2015) . For example, in the European ECLAIRE emissions (V4a) by Klimont et al (2013) , the decrease in anthropogenic ozone precursor emissions is strong both for the 'current legislation' (CLE) and for the 'maximally technically feasible' (MTF) scenarios until 2050. The CLE describes enforcement of all current legislative measures until 2030, but no additional measures, and has smaller decreases in precursor emissions compared to the MTF. Projections of future near-surface ozone concentrations, based on such future emission scenarios, result in a strong decrease in future ozone concentrations in Europe (Markakis et al 2016 , Watson et al 2016 .
Past studies have estimated the future health effects of summertime ozone (Ebi and McGregor 2008 , Sujaritpong et al 2014 , Orru et al 2017 and high temperatures (Huang et al 2011 , Sanderson et al 2017 globally, regionally, and locally, but very few have explored the long-term effects of ozone (Seltzer et al 2018) , and ozone and temperatures simultaneously (Lee et al 2017) . Moreover, there is limited knowledge about how other factors, such as decreases in ozone precursor emissions (Geels et al 2015 and changes in susceptible populations (Arbuthnott et al 2016 , Petkova et al 2017 might affect projected health burdens.
We project changes in ozone-and heat-related mortality in Europe and explore the individual and joint effects of climate, ozone precursor emissions, and demographic change.
Methods
The methods for calculating European-wide (EU-27, Norway, Switzerland) near-surface temperature and ozone concentrations are described elsewhere (Lacressonnière et al 2016, Markakis et al 2016 , Watson et al 2016 . In summary, both climate and air pollution were modelled at a horizontal resolution of 0.44°× 0.44°(ca 50 km×50 km) covering Europe (the full domain is the EURO-CORDEX domain, which is slightly larger than that which is shown in this analysis). For the calculation of temperature and other meteorological variables used as input to the air pollution dispersion model, the global climate model EC-EARTH was applied, downscaled with the Rossby Climate regional climate model RCA4 (Strandberg et al 2015) forced by the representative concentration pathway scenario RCP4.5 ( MATCH has been used extensively to study the connections between climate change and air quality in Europe (e.g. Engardt et al 2009, Engardt 2010, Watson et al 2016) . The photochemistry of the MATCH model considers time of day, latitude, and cloudiness, where the photochemical reaction rates were adjusted for cloud cover. Biogenic emissions of isoprene were modelled online, dependent on temperature and solar radiation, while soil moisture was not taken into account for the online emissions. This is likely to cause an overestimation in the change to the future of biogenic emissions, especially in southern Europe. The dry deposition is dependent on boundary layer meteorology, as well as on parameters affecting vegetation uptake, such as soil and air moisture, temperature, and solar radiation. This was previously shown to be important for modelling future near-surface ozone in southern Europe, particularly in the Iberian Peninsula (Andersson and Engardt 2010) . Natural NOx emissions from lightning were not included, while wildfires were included from the Atmospheric Chemistry and Climate Model Intercomparison Project (ACCMIP) database (Lamarque et al 2010) .
Gridded population data for Europe in 2010 and 2050 were obtained from the Integrated Assessment of Health Risks of Environmental Stressors in Europe (INTARESE) and Health and Environment Integrated Methodology and Toolbox for Scenario Development (HEIMSTA), where the current and future gridded population data sets were constructed (Kuhn et al 2011) . Based on these, the population-weighted ozone exposure in each country was calculated (see methods and equations in more detail in supplementary material and (Orru et al 2009 , Orru et al 2013 ). Data and projections regarding high temperatures among the total population and the population above 65 years of age were collected on a spatial scale of a similar resolution as the climate data for 2000 and 2050 (Kuhn et al 2011) . Each population data point was assigned to the closest climate data grid square central point (see methods in more detail in Åström et al 2017) .
The average baseline all-cause mortality rates in 2010 were attained from WHO's European Health for All Database (WHO 2019) and applied to all grids within each country. Each driver (climate, ozone precursor emissions, population) was projected individually, keeping other factors constant, to explore the effects of the individual drivers (e.g. ozone or temperature) on future mortality change. To describe the ozone effects associated with long-term and shortterm exposures, the exposure-response functions (relationship between exposure to pollution as a cause and specific health outcomes as a response) from earlier epidemiological studies were applied. For the calculation of long-term effects, the Hazard Ratio, HR=1.014 (95% CI 1.007-1.028) per 10 μgm −3 increase in annual mean of daily 8 h maximum from Turner et al (2016) was used; this study quantified the long-term effects of ozone. For short-term exposure effects, the Relative Risk, RR=1.0031 (95% CI 1.0017, 1.0052) per increase in the 8 h ozone max concentration by 10 μgm −3 from Gryparis et al (2004) was applied; this study quantified short-term ozone effects. The numbers of premature mortalities were calculated based on health impact assessment principles and equations described in more detail in (Orru et al 2013) . In the health impact assessment, usual cut-off values were applied, representing concentrations close to natural background not associated with an increase in risk (Lehtomäki et al 2018) . In the current study, the 25 ppb cut-off value was applied to the calculations for effects of long-term ozone exposure, and SOMO10, SOMO25 and SOMO35 (sum of means over 10, 25 and 35 ppb) values were used for the short-term effect calculations.
To measure harmful exposures from high temperatures, we used the framework from a European multi-city study within the Public Health Adaptation Strategies to Extreme Weather Events (PHASE) project. The estimated risk increase in that study was based on the difference in mortality between the 75th and the 99th percentile of summer daily mean temperatures (de'Donato et al 2015). We used a 22.9% increase in mortality associated with a temperature increase from the 75th to the 99th percentile (exposure-response function (ERF)) averaged over all cities in the PHASE study.
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Results

Current
Much larger decreases (−30% EU-wide) in ozonerelated mortality are projected due to reductions in ozone precursor emissions (table 1). The overall decrease could vary from −37% in Bulgaria to −7% in Netherlands and Luxembourg. In general, larger decreases are expected in Eastern-European countries and smaller decreases in Central-European countries. Summing all different factors together, a −28% decrease in ozone-related mortality could be expected EU-wide by 2050 (table 1) .
High ambient temperatures currently have a very similar magnitude of health burden relating to exposure to near-surface ozone (1% smaller). There are significant differences between countries: Belgium, Finland, Germany, Ireland, Luxembourg, the Netherlands, Sweden, and the UK have significantly higher burdens, and Bulgaria, Cyprus, Greece, Italy, Portal, and Spain have lower health burdens compared with that of ozone. With climate change and increased temperatures, heat-related mortality is expected to increase by 59% EU-wide by 2050. The increase will be largest in already warm countries as Cyprus, Greece, Italy, Portugal, and Spain, with smaller increases expected in Baltic and Eastern-European countries like Latvia, Lithuania, Poland and the Czech Republic (table 1).
Discussion
The health burdens associated with exposure to nearsurface ozone levels were projected to change in the future, with increases due to climate change and the size of susceptible populations in Europe, and decreases due declining concentrations of ozone precursor emissions; the net result was projected to be a decrease in the total health burden in 2050. Increasing temperatures as a result of climate change were projected to double heat-related mortality, making heat a larger health threat in the future. This is the second large-scale study where these two important health factors were combined in the same population using a similar climate model and scenarios. Lee et al (2017) projected smaller future heat-related mortality increases in Korean cities, while the effects of climate change on ozone-related mortality remained the same order of magnitude, slightly increasing or decreasing depending on the city and RCP used (Lee et al 2017) .
The average heat-mortality relationship from the PHASE study was used in our analyses because many countries did not have a country-specific exposureresponse function calculated in that study. Therefore, using the average European function was the best way to generate estimates for all countries.
We focused on RCP4.5, a rather optimistic scenario compared to RCP8.5. Even so, under RCP4.5 around a 2°C global average temperature increase can be expected by 2050 (IPCC 2013), which is the threshold increase under the Paris Agreement. We project up to a 59% increase in heat-related mortality in 2050 compared to 2000 if the 2°C threshold is accomplished, a significant and concerning increase.
Compared with earlier large-scale studies in Europe (Orru et al 2013 , Patz et al 2014 , Geels et al 2015 , Silva et al 2017 , we found the impact of climate change on ozone-related mortality was somewhat smaller. One difference in this analysis is that we included the health impacts of ozone exposure over the long term, while the earlier estimates were based on only short-term exposure, which might have underestimated the total near-surface ozone burden in Europe but overestimated the change. If we compare the climate change-related effects using only short-term exposures as SOMO35, the effects of climate are of the same magnitude as reported previously (Orru et al 2013) . This indicates that climate could have a larger effect on very high short-term concentrations of nearsurface ozone. Compared to the recent study by Seltzer et al (2018) , we found somewhat larger effects of nearsurface ozone for Europe, as our estimates are based on all-cause mortality.
As shown in sensitivity analysis in earlier studies (Malley et al 2017) , ozone health effects are highly sensitive to the threshold levels assumed: e.g. 10, 25, 27.7, 31.1, 33.3, 35, 41 .9 ppb. As the epidemiological studies quantified health effects at lower concentrations (Bell et al 2006) , we used a 25 ppb threshold as the main scenario. We applied only one climate model and one RCP scenario, to show the sensitivity of the projections to other important variables. The results will vary depending on the climate model and greenhouse gas emission scenarios used, both for temperature (Åström et al 2017) and for ozone (Post et al 2012) . A key difference with earlier studies is that we used a different greenhouse gas emission scenario to project the impact of climate change on ozone-related mortality. In our earlier analysis (Orru et al 2013) , we applied the A2 and A1B greenhouse gas emission scenarios using the global climate models ECHAM4 and HadCM3, respectively, and the MATCH version was different. A2 is more pessimistic in terms of greenhouse gas emissions than RCP4.5 and HadCM3 has a stronger climate sensitivity. Geels et al (2015) used the same greenhouse gas emission scenario used in this study, but used the global climate model ECHAM5 instead of EC-EARTH.
In this study, we used a relatively coarse resolution (0.44°×0.44°) that does not take into account a decrease of ozone by the titration effect of nitrogen oxide (NO) in city centres. This means that ozone exposure was likely overestimated close to where high emissions occur (e.g. Markakis et al 2016) , but underestimated in suburban areas in the outskirts of city centres where local emissions could increase near-surface ozone. Measures to reduce NO emissions locally may have the counter-benefit of increasing ozone exposure. This also means that our coarse resolution may result in overestimation of the change in population exposure due to emission change in the future. It is currently not technically feasible to describe ozone exposure at a very high resolution to take this effect into account across all of Europe. NO X emissions do also affect fine particle (PM 2.5 ) levels through formation of ammonium nitrate particles that has a substantial effect on public health, but this effect is not taken into account in this study. Further research is needed in those areas.
In our assessment, we applied population change by 2050, but did not assess the sensitivity of changes in mortality rates in 2050 as was done by Sun et al (2015) . Because mortality rates have been decreasing in Europe, this could have been another reason why the projected health effects on SOMO35 levels were smaller than in earlier publications (Orru et al 2013) . It is possible that population growth could be faster, which would make future health burdens even larger (table  S3) . Also, we did not consider the possible effects of future adaptation to warmer temperatures by the atrisk population because the modelling of adaptation to warmer temperatures is currently arbitrary and simplistic (Sanderson et al 2017) . In this analysis, we only projected the increase of heat-related mortality, and we did not take into account that there may be somewhat smaller decreases of cold-related mortality in some countries with climate change .
In our analyses, some countries currently have higher ozone-related health burdens compared to heat effects and vice versa (e.g. Spain with higher ozone versus Sweden with higher heat-related health burdens). On the one hand, this might be driven by the higher proportion of respiratory mortality in the total cardiopulmonary burden in 2010, indicating the high sensitivity of baseline mortality data. On the other hand, there are differences in heat sensitivity, with people in colder climates tending to be more sensitive to high temperatures than people in warmer climates (Medina-Ramon and Schwartz 2007).
The emission scenario ECLIPSE v4a (current legislation; (Klimont et al 2013) ) features a strong decrease in anthropogenic ozone precursor emissions from present to future, resulting in significantly lower concentrations of anthropogenic ozone (Markakis et al 2016 , Watson et al 2016 that in turn results in reduced ozone-related health effects. Similar declines in ozone future precursor emissions in Europe were projected (Doherty et al 2017) . However, there are inherent uncertainties related to future greenhouse gas emissions and the resulting climate change that could impact projected air pollution-related health impacts (Orru et al 2017) . The decreases in future emissions could be lower than expected based on different emission inventory estimates and earlier projections for NO X , VOC and NH 3 (Amann et al 2015) . NO 2 levels have stabilised in recent years in several monitoring sites in Europe (Guerreiro et al 2014) . Low percentiles of ozone in European and USA cities are increasing, while peak values are decreasing (Paoletti et al 2014) ; similar trends have been confirmed by modelling .
Ozone precursors were projected to increase in Asia (Lin et al 2017) and somewhat in the US (Wu et al 2008) over the same time period. How this global increase would increase background near-surface ozone levels is not yet clear. Also, under a higher greenhouse gas emission scenario, such as RCP8.5 with high global methane concentrations, the transboundary transport of ozone could be accelerated and cancel the projected benefits of European emission reductions on air quality (Fortems-Cheiney et al 2017). Fulfilling the Paris Agreement aims is essential to reduce emissions and protect health. We also should clearly communicate the future negative health burden possible under the Paris Agreement. Certainly we could expect increases in heat-related mortality in Europe that would require even better health policies and programs to protect increasing susceptible and aging populations.
Conclusions
Climate and emission changes will substantially affect ozone and heat-related mortality and the ratio between them in the middle of this century in Europe. Heat will become a more important health concern in the future, emphasising the importance of increasing resilience to a warmer world.
Although near-surface ozone-related mortality is projected to be smaller in the future (mainly due to precursors emission decrease), the reduction is not as large as it could be because of climate change and an increasingly susceptible population. Therefore, it is essential to continue to decrease ozone precursor emissions.
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